Search
for
Sort by
Research 31–60 of 111
- Novel therapies for alopecia areata: The era of rational drug development
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Treating Alopecia Areata: Current Practices Versus New Directions
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Immune therapies for alopecia areata: evidence and new perspectives
- Systemic Therapies for Scarring and Non-scarring Alopecia
- New Modalities in the Treatment of Refractory Alopecia Areata
- Efficacy and Safety of Tofacitinib in Paediatric Alopecia Aerata - A Prospective Observational Study
- New Drugs for Alopecias
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Recent Advances in Drug Development for Hair Loss
- An Updated in the Management of Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- ENZYMES
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Enzymes